Exact Sciences, US30063P1057

Exact Sciences stock heads into the open after Nasdaq gains

Published on 09/22/2026 at 05:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 18, 2026, Exact Sciences stock posted a positive Nasdaq session as the Nasdaq Composite gained 2.26 percent to 27,122.09. The next US session begins before today develops.

Wissenschaftlerinnen analysieren Krebsproben in einem modernen Diagnostiklabor von Exact Sciences
Exact Sciences Corp. betreibt hochmoderne Labore für die molekulare Krebsfrüherkennung weltweit ISIN US30063P1057, Illustration mit AI erstellt.

Exact Sciences stock closed higher on the Nasdaq on September 18, 2026, in USD terms, according to the dated market report. The Nasdaq Composite rose 2.26 percent to 27,122.09 in the same session, providing a quantified market comparison.

September 18, 2026 in numbers

Exact Sciences Corp. (ISIN US30063P1057, Nasdaq: EXAS) traded between a documented intraday low and high on the Nasdaq, with the close above the low and below the high. The session also recorded increased trading activity versus earlier in the week, according to the market report.

The broader backdrop was constructive: CNBC reported that the S and P 500 climbed 1.5 percent and the Nasdaq Composite jumped 2.3 percent on September 21, 2026, while lower oil prices supported the wider market.

September 22, 2026 outlook

Exact Sciences enters the US session after the latest documented company-specific update identified by Ad hoc News as a September 18, 2026 Nasdaq gain. Market-related attention includes the Richmond Federal Reserve manufacturing survey and scheduled Federal Reserve speeches on September 22, 2026, as reported by CNBC.

Disclaimer...

en | US30063P1057 | EXACT SCIENCES | boerse | 70150020 | bgmi